Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
本文由MarketWatch使用Automated Insights的技术自动生成。
Shares of Quest Diagnostics Inc. (DGX) rose 1.94% to $144.78 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.82% to 4,646.71 and Dow Jones Industrial Average falling 0.66% to 36,079.94. Quest Diagnostics Inc. closed $15.78 short of its 52-week high ($160.56), which the company reached on September 9th.
Quest Diagnostics Inc.股价周三上涨1.94%，至144.78美元，盘中股市全面低迷，标准普尔500指数下跌0.82%，至4,646.71点，道琼斯工业股票平均价格指数下跌0.66%，至36,079.94点。Quest Diagnostics Inc.收盘价比该公司9月9日创下的52周高点(160.56美元)低15.78美元。
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Laboratory Corp. of America Holdings (LH) rose 2.64% to $283.84, Qiagen N.V. (QGEN) rose 0.28% to $53.25, and Sonic Healthcare Ltd. ADR fell 1.20% to $28.86. Trading volume (963,032) remained 356,500 below its 50-day average volume of 1.3 M.
周三，与一些竞争对手相比，该股表现喜忧参半，美国实验室控股公司(Laboratory Corp.of America Holdings)上涨2.64%，至283.84美元，启根公司(Qiagen N.V.)上涨0.28%，至53.25美元，Sonic Healthcare Ltd.美国存托凭证(Sonic Healthcare Ltd.)下跌1.20%，至28.86美元。成交量(963,032口)仍较其50天平均成交量130万口低356,500口。
Data source: Dow Jones Market Data, FactSet. Data compiled November 10, 2021.
数据来源：道琼斯市场数据，FactSet。数据汇编于2021年11月10日。
-MarketWatch Automation
-MarketWatch自动化